A Study to Evaluate the Effectiveness and Safety of CAEL-101 in Patients With AL Amyloidosis
Condition: AL Amyloidosis Interventions: Drug: CAEL-101; Other: Placebo; Drug: cyclophosphamide, bortezomib, and Dexamethasone (CyBorD) Sponsors: Caelum Biosciences; IQVIA Biotech Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials